Flexible Modelling in Survival Analysis. Structuring Biological Complexity from the Information Provided by Tumor Markers

The aim of the present article is to introduce and discuss the problem of optimal modelling of the prognostic information provided by putative prognostic variables, possibly measured on a quantitative scale. A number of methodological aspects will be treated, with particular reference to the role of spline functions and artificial neural networks, which will be discussed in the context of the analysis of survival data. The problem of the evaluation and the choice of the optimal statistical models will be examined, with particular attention to the critical aspects related to the definition of prognostic indexes on the basis of the results of the selected models. Clinical examples in breast cancer on the evaluation of the prognostic impact of several tumor markers are provided. This paper is addressed to all researchers who are interested in the evaluation of the prognostic role of tumor markers, therefore we will stress the necessity of integrating the methodologies of biological, clinical and statistical research in the assessment of prognosis.

[1]  Brian D. Ripley,et al.  Statistical Ideas for Selecting Network Architectures , 1995, SNN Symposium on Neural Networks.

[2]  E. Biganzoli,et al.  Impact of Steroid Receptors, pS2 and Cathepsin D on the Outcome of N+ Postmenopausal Breast Cancer Patients Treated with Tamoxifen , 1998, The International journal of biological markers.

[3]  P. J. Verweij,et al.  Penalized likelihood in Cox regression. , 1994, Statistics in medicine.

[4]  U. Veronesi,et al.  Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  A Morabito,et al.  Prognostic factors and risk groups: some results given by using an algorithm suitable for censored survival data. , 1983, Statistics in medicine.

[6]  R. Simon,et al.  A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. , 1996, Statistics in medicine.

[7]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[8]  Charles Kooperberg,et al.  Trees and splines in survival analysis , 1995, Statistical methods in medical research.

[9]  P. Grambsch,et al.  Martingale-based residuals for survival models , 1990 .

[10]  C. Hill.  Valeur pronostique d'une variable continue et point de césure optimal. , 1993 .

[11]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[12]  D Faraggi,et al.  A neural network model for survival data. , 1995, Statistics in medicine.

[13]  L. Mariani,et al.  Clinically Useful Measures to Assess the Effectiveness of Treatments: Hints for a Proper Choice with Special Emphasis on Cancer Research , 1990, Tumori.

[14]  K. Liestøl,et al.  Survival analysis and neural nets. , 1994, Statistics in medicine.

[15]  B. Efron.  Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve , 1988 .

[16]  W. Catalona,et al.  Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. , 1994, The Journal of urology.

[17]  E Biganzoli,et al.  Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. , 1998, Statistics in medicine.

[18]  P. J. Verweij,et al.  Cross-validation in survival analysis. , 1993, Statistics in medicine.

[19]  J. Neijt,et al.  Predictability of the survival of patients with advanced ovarian cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  James L. McClelland,et al.  Parallel distributed processing: explorations in the microstructure of cognition, vol. 1: foundations , 1986 .

[21]  D. Coradini,et al.  Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: An exploratory investigation , 1998, International journal of cancer.

[22]  R Simon,et al.  Measures of explained variation for survival data. , 1990, Statistics in medicine.

[23]  F. Harrell,et al.  Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.

[24]  M. Barbareschi,et al.  Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy. , 1995, The cancer journal from Scientific American.

[25]  E Biganzoli,et al.  Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  H. Burke,et al.  Artificial neural networks for cancer research: outcome prediction. , 1994, Seminars in surgical oncology.

[27]  H. Kappen,et al.  Neural network analysis to predict treatment outcome , 1993 .

[28]  M. Fernö,et al.  Indicators of prognosis in node-negative breast cancer. , 1990, The New England journal of medicine.